"Phosphoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D010750
|
MeSH Number(s) |
D12.776.744
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Phosphoproteins".
Below are MeSH descriptors whose meaning is more specific than "Phosphoproteins".
This graph shows the total number of publications written about "Phosphoproteins" by people in this website by year, and whether "Phosphoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2008 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphoproteins" by people in Profiles.
-
Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells. Mol Endocrinol. 2008 Jul; 22(7):1606-21.
-
Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer. 2008 Apr 01; 122(7):1611-7.
-
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008 Mar; 40(3):310-5.
-
Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer. 2005 May 20; 115(1):148-54.
-
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res. 2005 Feb 15; 65(4):1213-22.
-
Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1206-14.